Women may experience substantial weight loss with this treatment, and it works equally well whether youre premenopausal, perimenopausal, or postmenopausal
Their anti-inflammatory effects may theoretically provide mild benefit, though this has not been confirmed in clinical trials focused on Hashimoto's specifically
That same month, a Wegovy-related NAION lawsuit was filed in New Jersey Superior Court
The cardiovascular risk reduction indication is coverable under Part D with prior authorization for members with established CVD who are overweight or obese
Despite the overwhelming success of GLP-1 medications related to weight loss, GLP-1 therapy is associated with increased cerebral blood flow and reduced small-vessel disease burden, even when controlling for weight loss [15]
Medical Aesthetics News Portland, OR July 24, 2026 By Cosmetiq Medicine A clinical review published this week put a number on something injectors have been watching for three years: the facial changes that follow rapid weight loss on GLP-1 medications are now driving measurable demand for aesthetic treatment
